Medicare Enrolled

Dr. Ashish Shah, MD

Pediatric Hematology-Oncology · Morristown, NJ
Low-engagement
100 MADISON AVE, Morristown, NJ 07960
9739717185
In practice since 2006 (20 years)
NPI: 1003880329 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shah

Dr. Ashish Shah is a pediatric hematology-oncology specialist in Morristown, NJ, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Shah received a total of $2,227 from 45 pharmaceutical and/or device companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology-oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shah is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $2,227 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,227
Total received (2018-2024)
Avg $318/year across 7 years
Top 21% in NJ for pediatric hematology-oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
137
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,227 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$280
2023
$147
2022
$391
2021
$258
2020
$203
2019
$497
2018
$451

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Philips North America LLC
$182
AstraZeneca Pharmaceuticals LP
$30
Adaptive Biotechnologies Corporation
$23
Regeneron Healthcare Solutions, Inc.
$16
VERTEX PHARMACEUTICALS INCORPORATED
$15
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 83.8% of 2024 payments
All-time payments by company (2018-2024) ›
Philips Electronics North America Corporation
$253
Philips North America LLC
$182
AstraZeneca Pharmaceuticals LP
$166
Covis Pharma GmBH
$115
GlaxoSmithKline, LLC.
$111
VERTEX PHARMACEUTICALS INCORPORATED
$98
Chiesi USA, Inc.
$89
Allergan Inc.
$89
Medtronic Vascular, Inc.
$85
Gilead Sciences, Inc.
$77
Vertex Pharmaceuticals Incorporated
$70
AbbVie Inc.
$68
ALCRESTA THERAPEUTICS, INC.
$60
Jazz Pharmaceuticals Inc.
$58
JAZZ PHARMACEUTICALS INC.
$46
Teva Pharmaceuticals USA, Inc.
$44
Novartis Pharmaceuticals Corporation
$43
Baxter Healthcare
$40
Kite Pharma, Inc.
$38
Astellas Pharma US Inc
$35
GENZYME CORPORATION
$29
E.R. Squibb & Sons, L.L.C.
$28
AbbVie, Inc.
$28
VIVUS, Inc.
$26
Daiichi Sankyo Inc.
$26
Biogen, Inc.
$25
CHIESI USA, INC.
$23
Adaptive Biotechnologies Corporation
$23
Janssen Biotech, Inc.
$21
Electromed, Inc.
$19
PORTOLA PHARMACEUTICALS, INC.
$19
Regeneron Healthcare Solutions, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Novo Nordisk Inc
$16
Insmed, Inc.
$15
Kyowa Kirin, Inc.
$15
Amgen Inc.
$14
Eisai Inc.
$14
Covis Pharma B.V.
$14
Harmony Biosciences LLC
$14
Exelixis Inc.
$13
NESTLE HEALTHCARE NUTRITION INC.
$13
Seattle Genetics, Inc.
$12
Puma Biotechnology, Inc.
$12
Monaghan Medical Corporation
$11
Top 3 companies account for 27.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ADCETRIS · ALVESCO · AeroChamber · Amplia MRI · Arikayce · BETHKIS · BEVESPI AEROSPHERE · BEVYXXA · BRONCHITOL · CREON · Cabometyx · Cayston · Creon · DUPIXENT · FASENRA · FIASP · Hillrom - Volara System · INJECTAFER · Lenvima · NUCALA · Nerlynx · OPDIVO · OPDUALAG · PANCREAZE · PERTZYE · POTELIGEO · QVAR · RELIZORB · SMARTVEST · SPINRAZA · SPIRIVA RESPIMAT · SUNOSI · SYMBICORT · TASIGNA · TECVAYLI · TEZSPIRE · TRIKAFTA · VYXEOS · Wakix · XYWAV · Xospata · ZENPEP · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatric hematology-oncology specialist in Morristown?
Compare pediatric hematology-oncologists in the Morristown area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology-oncologists nearby

Geographic Context

Pediatric hematology-oncologists within 10 mi
27
Per 100K population
5.3
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shah is a pediatric hematology-oncology specialist, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $2,227 from 45 companies across 137 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Hematology-Oncologists in Morristown
Browse pediatric hematology-oncologists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Hematology-Oncologists in NJ
Pediatric hematology-oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Hematology-Oncologists in NJ
Which NJ pediatric hematology-oncologists receive the most from drug and device companies.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
By company
Philips North America LLC Payments to Doctors
See all physicians who received payments from Philips North America LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →